Cerevel Therapeutics Hldg Inc (CERE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Operating Expenses | 54,527 | 50,510 | 50,571 | 41,896 | 34,362 |
| Operating Income | -54,527 | -50,510 | -50,571 | -41,896 | -34,362 |
| Other Income | -7,532 | -2,729 | -410 | 8,716 | -4,683 |
| Pre-tax Income | -62,059 | -53,239 | -50,981 | -33,180 | -39,045 |
| Income Tax | N/A | N/A | N/A | -13 | 5 |
| Net Income Continuous | -62,059 | -53,239 | -50,981 | -33,167 | -39,050 |
| Net Income | $-62,059 | $-53,239 | $-50,981 | $-33,177 | $-39,040 |
| EPS Basic Total Ops | -0.43 | -0.42 | -0.40 | -0.08 | -0.62 |
| EPS Basic Continuous Ops | -0.43 | -0.42 | -0.40 | -0.14 | -0.62 |
| EPS Diluted Total Ops | -0.43 | -0.42 | -0.40 | -0.08 | -0.62 |
| EPS Diluted Continuous Ops | -0.43 | -0.42 | -0.40 | -0.14 | -0.62 |
| EBITDA(a) | $-53,547 | $-49,909 | $-50,508 | $-41,835 | $-34,311 |